Provided by Tiger Trade Technology Pte. Ltd.

IDEXX Laboratories

519.84
+9.111.78%
Volume:139.18K
Turnover:71.89M
Market Cap:41.01B
PE:36.53
High:520.41
Open:511.56
Low:509.44
Close:510.73
52wk High:769.98
52wk Low:500.61
Shares:78.88M
Float Shares:78.57M
Volume Ratio:0.46
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.23
EPS(LYR):13.08
ROE:74.21%
ROA:27.08%
PB:25.43
PE(LYR):39.74

Loading ...

Will In-Clinic Cardiac Testing Expansion via Catalyst proBNP Test Change IDEXX Laboratories' (IDXX) Narrative

Simply Wall St.
·
Aug 20

Zoetis Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 20

IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 19

IDEXX Laboratories Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 15

IDEXX Publishes Investor Day Presentation on Diagnostics Innovation, Software and AI Growth Strategy

Reuters
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Idexx Laboratories (IDXX)

TIPRANKS
·
Aug 14

IDEXX (IDXX) Stock Looks Fair On Cash Flow But Rich On Earnings

Simply Wall St.
·
Aug 13

Zoetis Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

IDEXX Laboratories Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

IDEXX Labs is Maintained at Overweight by Barclays

Dow Jones
·
Aug 11

Idexx Laboratories announces launch of Catalyst proBNP Test

TIPRANKS
·
Aug 11

Idexx Laboratories price target lowered to $710 from $800 at Barclays

TIPRANKS
·
Aug 11

Revvity Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 11

IDEXX Laboratories Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Zoetis Inc. Stock Slips 6.0%, Underperforms Peers

Dow Jones
·
Aug 08

How IDEXX’s Raised 2026 Earnings Outlook Will Impact IDEXX Laboratories (IDXX) Investors

Simply Wall St.
·
Aug 06

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

IDEXX Labs is Maintained at Neutral by UBS

Dow Jones
·
Aug 06

UBS Adjusts Price Target on IDEXX Laboratories to $670 From $620, Maintains Neutral Rating

MT Newswires Live
·
Aug 05

IDEXX Laboratories Inc : UBS Raises Target Price to $670 from $620

THOMSON REUTERS
·
Aug 05